Co-Adjuvant Intravenous Corticosteroids for Septic Arthritis (CICSA): A Proposal of a Multicenter Randomized Controlled Trial
Daniel Pérez‐Prieto, Roger Rojas-Sayol, Lluisa Sorlí, Sònia Luque et autres
0 citationsOsteology
Joan Gómez‐Junyent
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
84Publications signalées
1941Citations signalées
6Affiliations récentes
Institutions déclarées
Domaines associés
Orthopedic Infections and TreatmentsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchAntibiotic Resistance in BacteriaParasites and Host Interactions
Publications récentes
Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial
Francesco Cogliati Dezza, L. Barrera Pulido, Irene Borreguero, Fernando Docobo Pérez et autres
1 citationThe Lancet
Intrapulmonary penetration of ceftolozane/tazobactam and ceftazidime/avibactam administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Adela Benítez-Cano, Aymara Sancho‐Araiz, Jesús Carazo, Isabel Ramos et autres
1 citationCritical Care
Genomic profile of extraintestinal pathogenic Escherichia coli isolates from prosthetic joint infections: The search for molecular fingerprints
María Ángeles Meléndez-Carmona, M. Carmen Martín-Higuera, Raúl Recio, Eva Benavent et autres
0 citationsFigshare
Genomic profile of extraintestinal pathogenic Escherichia coli isolates from prosthetic joint infections: The search for molecular fingerprints
María Ángeles Meléndez-Carmona, M. Carmen Martín-Higuera, Raúl Recio, Eva Benavent et autres
0 citationsFigshare
¿EXISTE MARGEN PARA ESPACIAR LA ADMINISTRACIÓN DE DOSIS MÚLTIPLES DE DALBAVANCINA? EVIDENCIA EN PRÁCTICA REAL MEDIANTE MONITORIZACIÓN FARMACOCINÉTICA
Joan Torra-Garcia, Joan Gómez‐Junyent, Maria Luisa Sorlí Redó, Rosario Bueno-Uceda et autres
0 citations
Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections
Rosa Escudero-Sánchez, Laura Morata, Luís Buzón, Sofía de la Villa et autres
0 citationsAntibiotics
2025 ICM: Debridement, Antibiotics, and Implant Retention
James Cashman, Seyed Mohammad Javad Mortazavi, Pier Francesco Indelli, Siddharth Rele et autres
8 citationsThe Journal of Arthroplasty
2025 ICM: Minimum Biofilm Eradication Concentration (MBEC) Versus Minimum Inhibitory Concentration (MIC)
Martin Kršák, Sherif Ahmed Khaled, Jose Franciso Reyes Copello, Kayahan Karaytuğ et autres
2 citationsThe Journal of Arthroplasty
2025 ICM: Use of Newer Antibiotics and Fluoroquinolone-Resistance
Fouad Sadek, Staffan Tevell, Jaime Lora-Tamayo, Р. М. Тихилов et autres
0 citationsThe Journal of Arthroplasty
Real-World Use of Dalbavancin in Diabetic Foot Osteomyelitis: PEDDAL Study
Leonor Moreno Núñez, Amparo Benito, Elena Bereciartúa, Laura Morata et autres
0 citationsJournal of Clinical Medicine
Challenges and strategies in the treatment of periprosthetic joint infection caused by multidrug-resistant Gram-negative bacteria: a narrative review
Joan Gómez‐Junyent, Jaime Lora‐Tamayo, Luisa Sorlí, Óscar Murillo
11 citationsClinical Microbiology and Infection
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.